| answer text |
<p>Epsom and St Helier University Hospitals NHS Trust has a strong track record of
providing high quality care to people with suspected or confirmed cases of cancer
in a timely manner. Last year, the Trust met all of the waiting time standards we
expect for cancer patients, including seeing 97.2% of patients with a suspected cancer
within two weeks of their general practitioners (GPs) referral, 99.1% of patients
began treatment with 31 days of diagnosis, and 89% of patients began treatment within
62 days of their initial referral.</p><p>Epsom and St Helier University Hospitals
NHS Trust is working on plans to improve the patient’s experience through their cancer
journey. This includes access to a clinical nurse specialist or key worker, and they
have recently appointed three Advanced Nurse Practitioners and funding approved to
increase number of clinical nurse specialists. The Trust is introducing ‘Living With
and Beyond Cancer’ – a new work stream to improve patient experience and care beyond
their diagnosis and initial treatment and improving quality of life for those living
with cancer. This includes NHS England and NHS Improvement data collection on long
term quality of life metrics, stratified follow up pathways, reducing and managing
long term outcomes of treatment, and Holistic Needs Assessments.</p><p>The Royal Marsden
NHS Foundation Trust is a research active organisation, with an academic partnership
with The Institute of Cancer Research, and, together, are ranked third in the world
for impact of their research. The Royal Marsden is continually looking to improve
the treatment options and facilities they offer to patients, including the first linear
accelerators (LINAC) in the country and third in the world, which is now treating
patients across six tumour types as part of clinical trials.</p><p>The Royal Marsden
is also the host of RM Partners, the only cancer alliance in England to achieve the
62 day target consistently during 2018/19 and which was awarded a further £10 million
in funding from NHS England to continue to improve cancer outcomes for the population
across west London.</p><p> </p>
|
|
